Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionCapital Advantage, Inc.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Capital Advantage, Inc. closes position in PFE / Pfizer Inc.

On January 7, 2026 - Capital Advantage, Inc. filed a 13F-HR form disclosing ownership of 0 shares of Pfizer Inc. (US:PFE) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 22, 2025 disclosing 9,187 shares of Pfizer Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-07 2025-12-31 13F PFIZER COM 717081103 0 -9,187 -100.00 0 -100.00
2025-10-22 2025-09-30 13F PFIZER COM 717081103 9,187 -159 -1.70 234 3.54 0.0352
2025-07-11 2025-06-30 13F PFIZER COM 717081103 9,346 -5,550 -37.26 227 -42.78 0.0359
2025-04-10 2025-03-31 13F PFIZER COM 717081103 14,896 0 0.00 395 0.00 0.0720
2025-02-14 2024-12-31 13F PFIZER COM 717081103 14,896 -5,404 -26.62 395 -32.71 0.0720
2024-11-07 2024-09-30 13F PFIZER COM 717081103 20,300 -1,729 -7.85 587 -4.55 0.1126
2024-07-12 2024-06-30 13F Pfizer Equities 717081103 22,029 16 0.07 615 -1.76 0.1261
2024-05-14 2024-03-31 13F Pfizer Equities 717081103 22,013 -232 -1.04 626 -2.19 0.1271
2024-01-23 2023-12-31 13F Pfizer Equities 717081103 22,245 -2,825 -11.27 640 -22.98 0.1300
2023-10-30 2023-09-30 13F Pfizer Equities 717081103 25,070 508 2.07 832 -5.14 0.1783
2023-08-07 2023-06-30 13F Pfizer Equities 717081103 24,562 -235 -0.95 876 -13.61 0.1828
2023-05-05 2023-03-31 13F Pfizer Equities 717081103 24,797 883 3.69 1,014 -17.22 0.2158
2023-01-24 2022-12-31 13F Pfizer Equities 717081103 23,914 -73 -0.30 1,225 16.67 0.2751
2022-10-31 2022-09-30 13F Pfizer Equities 717081103 23,987 1,951 8.85 1,050 -9.09 0.2403
2022-07-21 2022-06-30 13F Pfizer Equities 717081103 22,036 -797 -3.49 1,155 -2.28 0.2546
2022-05-10 2022-03-31 13F Pfizer Equities 717081103 22,833 791 3.59 1,182 -0.92 0.2718
2022-01-21 2021-12-31 13F Pfizer Equities 717081103 22,042 506 2.35 1,193 28.83 0.2859
2021-10-07 2021-09-30 13F Pfizer Equities 717081103 21,536 45 0.21 926 9.98 0.2502
2021-08-16 2021-06-30 13F Pfizer Equities 717081103 21,491 -12 -0.06 842 8.09 0.2207
2021-04-26 2021-03-31 13F Pfizer Com 717081103 21,503 1,738 8.79 779 5.99 0.2123
2021-02-17 2020-12-31 13F Pfizer COM 717081103 19,765 352 1.81 735 3.81 0.2191
2020-11-12 2020-09-30 13F Pfizer COM 717081103 19,413 -85 -0.44 708 10.97 0.2331
2020-08-13 2020-06-30 13F Pfizer COM 717081103 19,498 -275 -1.39 638 -12.60 0.2266
2020-05-08 2020-03-31 13F Pfizer COM 717081103 19,773 1,751 9.72 730 1.67 0.2851
2020-02-14 2019-12-31 13F Pfizer COM 717081103 18,022 -577 -3.10 718 7.49 0.2271
2019-11-12 2019-09-30 13F Pfizer COM 717081103 18,599 2,208 13.47 668 -4.02 0.2313
2019-05-10 2019-03-31 13F Pfizer COM 717081103 16,391 1,496 10.04 696 7.08 0.2472
2019-02-07 2018-12-31 13F Pfizer COM 717081103 14,895 84 0.57 650 -0.46 0.2465
2018-11-01 2018-09-30 13F Pfizer COM 717081103 14,811 -467 -3.06 653 17.87 0.1500
2018-08-01 2018-06-30 13F Pfizer COM 717081103 15,278 -785 -4.89 554 -2.81 0.1305
2018-05-02 2018-03-31 13F Pfizer COM 717081103 16,063 12 0.07 570 -1.89 0.1394
2018-02-13 2017-12-31 13F Pfizer COM 717081103 16,051 10 0.06 581 1.40 0.1498
2017-10-30 2017-09-30 13F Pfizer COM 717081103 16,041 -8,424 -34.43 573 -30.29 0.1434
2017-08-08 2017-06-30 13F Pfizer COM 717081103 24,465 -36 -0.15 822 -1.91 0.2154
2017-05-03 2017-03-31 13F Pfizer COM 717081103 24,501 2,728 12.53 838 18.53 0.2295
2017-02-01 2016-12-31 13F Pfizer COM 717081103 21,773 -623 -2.78 707 -6.85 0.2048
2016-11-02 2016-09-30 13F Pfizer COM 717081103 22,396 248 1.12 759 -2.69 0.2129
2016-08-10 2016-06-30 13F Pfizer COM 717081103 22,148 674 3.14 780 22.64 0.2265
2016-05-23 2016-03-31 13F Pfizer COM 717081103 21,474 6,375 42.22 636 30.60 0.2255
2016-02-26 2015-12-31 13F Pfizer COM 717081103 15,099 5 0.03 487 2.74 0.1642
2015-10-23 2015-09-30 13F Pfizer COM 717081103 15,094 1,178 8.47 474 1.50 0.1847
2015-08-14 2015-06-30 13F Pfizer COM 717081103 13,916 -395 -2.76 467 -6.22 0.1821
2015-05-15 2015-03-31 13F Pfizer COM 717081103 14,311 5 0.03 498 11.66 0.2044
2015-05-15 2014-12-31 13F Pfizer COM 717081103 14,306 522 3.79 446 9.31 0.1839
2016-06-21 2014-09-30 13F Pfizer COM 717081103 13,784 -127 -0.91 408 -1.21 0.2127
2016-07-15 2014-06-30 13F Pfizer COM 717081103 13,911 413 3.06 413 -4.84 0.2279
2016-08-09 2014-03-31 13F Pfizer COM 717081103 13,498 2,956 28.04 434 34.37 0.3023
2016-08-24 2013-12-31 13F Pfizer COM 717081103 10,542 10,542 323 0.2171
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.